by Christa Nuber | 6 min read
In early May 2021, the Centers for Disease Control and Protection (CDC), relaxed their face masking and social distancing restrictions for people who were fully vaccinated against SARS-CoV-2, the virus …
Read Storyby Neoteryx | 4 min read
Clinical trials are vital to advancing medical science, but they face many stumbling blocks. New technology has given researchers the ability to take clinical trials outside the trial site and …
Read Storyby Neoteryx | 2 min read
Biological specimens like saliva, blood, or urine are often collected for use in routine patient monitoring and population surveys. Population surveys are essential because they provide current, detailed health and …
Read Storyby Neoteryx | 2 min read
The rise of microsampling technology has dramatically simplified the process of specimen collection, whether for collecting blood or another bio-fluid. For blood collection, it is no longer necessary to undergo …
Read Storyby Neoteryx | 2 min read
When your are conducting a research study in a low-resource area and you need to collect blood samples via traditional venous puncture, there can be significant technological impediments. Tubes of …
Read StoryLearn about insights, research, case studies, and tutorials on integrating remote specimen collection, microsampling, and more!
© Neoteryx 2021 | Privacy Policy | Sitemap
421 Amapola Ave
Torrance, CA 90501
This site is protected by reCAPTCHA and the Google Privacy
Policy and Terms of Service apply.
Mitra® devices are intended as a specimen collector and for the storage and transport of biological fluids. They are CE-IVD self-certified in the UK and EU, a Class 1 IVD in Australia, Brazil & China, Class B in South Africa, and registered with health agencies in Canada, Thailand, and Ukraine. In the United States, Mitra devices are for Research Use Only (RUO). In some countries, Mitra devices may be used in clinical diagnostic laboratory systems after the laboratory has validated their complete system in compliance with relevant rules and regulations. Mitra is a registered trademark of Neoteryx, LLC.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
Copyright © 2022 Neoteryx, LLC, Part of the Trajan Family. All rights reserved.